- Home
- PHOS vs LFMD Comparison
PHOS vs LFMD Comparison
Compare PHOS & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHOS | LFMD |
|---|---|---|
| Founded | 2006 | 1994 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.7M | 218.1M |
| IPO Year | 2010 | 2012 |
Fundamental Metrics
Financial Performance| Metric | PHOS | LFMD |
|---|---|---|
| Price | $11.99 | $2.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $8.13 |
| AVG Volume (30 Days) | 23.5K | ★ 657.8K |
| Earning Date | 11-28-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 141.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,468,578.00 |
| Revenue This Year | N/A | $6.97 |
| Revenue Next Year | N/A | $18.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 49.79 |
| 52 Week Low | $11.23 | $2.10 |
| 52 Week High | $21.30 | $6.42 |
Technical Indicators
Market Signals| Indicator | PHOS | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 36.20 | 22.99 |
| Support Level | N/A | N/A |
| Resistance Level | $15.26 | $3.46 |
| Average True Range (ATR) | 1.00 | 0.13 |
| MACD | -0.20 | -0.03 |
| Stochastic Oscillator | 21.72 | 1.99 |
Price Performance
Historical ComparisonAbout PHOS First Phosphate Corp. American Depositary Shares
First Phosphate Corp owns and is developing igneous rock phosphate mineral properties in the Saguenay Region of Quebec for the production of phosphoric acid for the production of cathode active material for use in lithium iron phosphate (LPF) batteries for the electric vehicle industry.
About LFMD LifeMD Inc.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.